MEHLMAN CONSULTING, INC. for MERCK AND CO INC
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Support reauthorization of Prescription Drug User Fee Act and Better Pharmaceuticals for Children Act (S. 1080, H.R. 2900). Support efforts to promote public/private partnerships for health technology assessment (no specific legislation). Oppose efforts to permit Rx drug importation into U.S., other than by drug's manufacturer. (No specific bill) Support efforts to require safety and cost savings certification by HHS Sec'y in any Rx drug importation legislation (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | N/A |
| DAVID CASTAGNETTI | N/A |
| ELISE FINLEY PICKERING | CHIEF OF STAFF, REP. SHADDEGG; EXEC. DIR. RPC |
| KARIN HUDSON | N/A |
| BRUCE MEHLMAN | N/A |
| STACEY RAMPY | N/A |
| DEAN ROSEN | HEALTH POLICY DIRECTOR, SEN. BILL FRIST |
| DAVID R THOMAS | CHIEF OF STAFF, REP. ZOE LOFGREN |
| ALEX VOGEL | N/A |
Medicare/Medicaid MMM
Oppose efforts to amend Medicare Modernization Act to impose government price controls on prescription drugs (H.R. 4, S. 250). Support efforts to ensure appropriate access to vaccines under Medicare Part D (no specific bill). Oppose expansion of or increase in Medicaid rebate (no specific bill).
| Lobbyist | Covered position, as disclosed |
|---|---|
| KELLY RUCKER BINGEL | N/A |
| DAVID CASTAGNETTI | N/A |
| ELISE FINLEY PICKERING | CHIEF OF STAFF, REP. SHADDEGG; EXEC. DIR. RPC |
| KARIN HUDSON | N/A |
| BRUCE MEHLMAN | N/A |
| STACEY RAMPY | N/A |
| DEAN ROSEN | HEALTH POLICY DIRECTOR, SEN. BILL FRIST |
| DAVID R THOMAS | CHIEF OF STAFF, REP. ZOE LOFGREN |
| ALEX VOGEL | N/A |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.